• Who We Are
    • Board of Directors
    • Core Team
    • Medical and Research Members/Advisors
    • Patient and Patient Advocate Members/Advisors
    • Health Care and Public Sector Members/Advisors
    • Private Sector Members/Advisors
  • Why We Are
  • Articles
  • Contact Us
Archives
You are here: Home / Joan Schiller
The Urgent Need for Clinical Research Reform to Permit Faster, Less Expensive Access to New Therapies for Lethal Diseases

The Urgent Need for Clinical Research Reform to Permit Faster, Less Expensive Access to New Therapies for Lethal Diseases

October 14, 2015Written by David J Stewart, Gerald Batist, Hagop M. Kantarjian, Joan Schiller, John-Peter Bradford, Razelle Kurzrockin Articles

High costs of complying with drug development regulations slow progress and contribute to high drug prices and, hence, mounting health care costs.  If it is exorbitantly expensive to bring new therapies to approval, fewer agents can be developed with available resources, impeding the emergence of urgently needed treatments and escalating prices by limiting competition.  Excessive regulation produces numerous speed bumps on the road to drug authorization.  Although an explosion of knowledge could fuel rapid advances, progress has been slowed worldwide by inefficient regulatory and clinical research systems that limit access…

more

©2021 Life Saving Therapies Network | Powered by WordPress & Atlantis

  • Login